ArticleDermatology and therapy2024

Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60.

Alexander Egeberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.